RE: Less Fire,Less Patients ?30 Jan 2023 20:10
Fair enough..and thank you. My fear is that this drug (re P2 results) shone brightest amidst the most severe infections during the covid heights,when C-19 was raging through patients' bodies.That initial ,1st wave onslaught has now passed, obviously,so we are now hoping that we can find success via broad spectrum use.Are there many precedential cases where a drug has failed a P3 trial and went on to succeed under a different guise/useage ?